Inhibikase Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SANDS CAPITAL VENTURES, LLC | 08/13/2026 | 13.02 M | $26.43 M | 0.00% | 7.46% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 08/11/2026 | 10.88 M | $22.08 M | 0.00% | 6.23% |
| TRAILS EDGE CAPITAL PARTNERS, LP | 08/14/2026 | 9.05 M | $18.37 M | 12.34% | 5.18% |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 08/14/2026 | 8.63 M | $17.51 M | 0.00% | 4.94% |
| BLACKROCK, INC. | 08/07/2026 | 7.77 M | $15.77 M | 23.24% | 4.45% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 7.39 M | $15.00 M | 11.82% | 4.23% |
| BLACKSTONE INC. | 08/14/2026 | 5.94 M | $12.05 M | 0.00% | 3.40% |
| SIREN, L.L.C. | 08/13/2026 | 5.85 M | $11.88 M | 0.00% | 3.35% |
| COMMODORE CAPITAL LP | 08/14/2026 | 5.40 M | $10.96 M | 0.00% | 3.09% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 4.94 M | $10.02 M | 10.89% | 2.83% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 4.03 M | $8.18 M | 37.57% | 2.31% |
| SATURN V CAPITAL MANAGEMENT LLC | 08/14/2026 | 3.87 M | $7.85 M | 0.15% | 2.22% |
| KALEHUA CAPITAL MANAGEMENT LLC | 08/19/2026 | 3.82 M | $7.76 M | 0.00% | 2.19% |
| SPRUCE STREET CAPITAL LP | 08/13/2026 | 3.58 M | $7.27 M | 0.00% | 2.05% |
| SQUADRON CAPITAL MANAGEMENT LLC | 08/14/2026 | 3.00 M | $6.09 M | -14.29% | 1.72% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 08/19/2026 | 2.70 M | $5.48 M | 0.00% | 1.55% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 2.61 M | $5.29 M | 20.13% | 1.49% |
| STATE STREET CORP | 09/22/2026 | 1.91 M | $3.88 M | 13.24% | 1.09% |
| SUMMITTX CAPITAL, L.P. | 08/14/2026 | 1.78 M | $3.61 M | 16.77% | 1.02% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 08/14/2026 | 1.35 M | $2.74 M | 0.00% | 0.77% |
| NORTHERN TRUST CORP | 08/13/2026 | 878.59 K | $1.78 M | 22.23% | 0.50% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 809.49 K | $1.64 M | 31.04% | 0.46% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 806.26 K | $1.64 M | -4.88% | 0.46% |
| SPHERA FUNDS MANAGEMENT LTD. | 08/14/2026 | 649.31 K | $1.32 M | 100.00% | 0.37% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 607.26 K | $1.23 M | 7.10% | 0.35% |
| KENNONDALE CAPITAL MANAGEMENT LLC | 08/11/2026 | 565.98 K | $1.15 M | 100.00% | 0.32% |
| PATHSTONE HOLDINGS, LLC | 08/13/2026 | 510.60 K | $1.04 M | 100.00% | 0.29% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2026 | 468.20 K | $950.44 K | 172.19% | 0.27% |
| NUVEEN, LLC | 08/11/2026 | 425.49 K | $863.75 K | -9.93% | 0.24% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 08/17/2026 | 396.18 K | $804.24 K | -58.61% | 0.23% |
| SEVEN FLEET CAPITAL MANAGEMENT LP | 08/17/2026 | 346.90 K | $704.21 K | 6.54% | 0.20% |
| JPMORGAN CHASE & CO | 08/12/2026 | 316.57 K | $610.99 K | -3.64% | 0.18% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 303.13 K | $615.35 K | 42.17% | 0.17% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 275.04 K | $558.33 K | 16.83% | 0.16% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 275.04 K | $558.33 K | 100.00% | 0.16% |
| RANGELEY CAPITAL, LLC | 08/14/2026 | 220.00 K | $446.60 K | 0.00% | 0.13% |
| UBS GROUP AG | 08/13/2026 | 204.65 K | $415.45 K | -10.30% | 0.12% |
| BLAIR WILLIAM & CO/IL | 08/11/2026 | 156.08 K | $316.84 K | -1.21% | 0.09% |
| ALPS ADVISORS INC | 07/29/2026 | 134.00 K | $272.02 K | 100.00% | 0.08% |
| JONES FINANCIAL COMPANIES LLLP | 08/14/2026 | 128.49 K | $245.42 K | 299.04% | 0.07% |
| DEUTSCHE BANK AG\ | 08/07/2026 | 126.68 K | $257.15 K | 3.46% | 0.07% |
| RHUMBLINE ADVISERS | 08/12/2026 | 120.01 K | $243.62 K | 104.39% | 0.07% |
| MORGAN STANLEY | 08/13/2026 | 114.01 K | $231.43 K | -30.59% | 0.07% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 108.02 K | $219.29 K | -66.53% | 0.06% |
| FMR LLC | 08/13/2026 | 103.73 K | $210.57 K | 44.14% | 0.06% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 101.84 K | $206.74 K | 151.27% | 0.06% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 99.63 K | $203.00 K | 95.84% | 0.06% |
| CITADEL ADVISORS LLC | 09/02/2026 | 74.35 K | $150.93 K | -93.26% | 0.04% |
| IEQ CAPITAL, LLC | 08/11/2026 | 68.51 K | $139.08 K | 332.33% | 0.04% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 08/14/2026 | 62.52 K | $126.92 K | -0.62% | 0.04% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Inhibikase Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 126 institutional investors and hedge funds held shares of Inhibikase Therapeutics Inc. The most heavily invested institutionals were:
Sands Capital Ventures, LLC: 13.02 M
Soleus Capital Management, L.P.: 10.88 M
Trails Edge Capital Partners, LP: 9.05 M
Fairmount Funds Management LLC: 8.63 M
BlackRock, Inc.: 7.77 M
ADAR1 Capital Management, LLC: 7.39 M
67.67% of Inhibikase Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 122.81 M shares in the last 24 months. This purchase volume represents approximately $232.11 M in transactions.